HTN and antihypertensive data
| Increased BP | Stable BP | P value | |
| Mean preprocedural systolic BP (mm Hg) | 125.1 (17.8) | 120.2 (16.1) | 0.180 |
| Mean preprocedural diastolic BP (mm Hg) | 67.0 (10.2) | 67.0 (10.3) | 0.910 |
| Mean preprocedural pulse pressure (mm Hg) | 58.2 (16.1) | 53.9 (13.3) | 0.006 |
| Mean # of preprocedural BP meds | 2.23 (1.08) | 2.41 (1.17) | 0.150 |
| ACE inhibitor (%) | 31 | 35 | 0.415 |
| Angiotensin II receptor blocker (%) | 18 | 18 | 1.000 |
| Beta blocker (%) | 70 | 79 | 0.083 |
| Calcium channel blocker (%) | 27 | 31 | 0.470 |
| Thiazide diuretic (%) | 21 | 21 | 1.000 |
| Loop diuretic (%) | 48 | 50 | 0.827 |
| Spironolactone (%) | 4 | 3 | 1.000 |
| Mean post-TAVR systolic BP (mm Hg) | 125.2 (18.7) | 123.2 (20.1) | 0.350 |
| Mean post-TAVR diastolic BP (mm Hg) | 59.6 (15.0) | 59.0 (14.3) | 0.713 |
| Mean post-TAVR pulse pressure (mm Hg) | 65.6 (18.2) | 64.2 (18.3) | 0.500 |
| Mean # of BP meds at 1 year post-TAVR | 2.77 (0.92) | 2.19 (1.06) | <.001 |
| ACE inhibitor (%) | 39 | 27 | 0.176 |
| Angiotensin II receptor blocker (%) | 22 | 20 | 1.000 |
| Beta blocker (%) | 88 | 81 | 0.250 |
| Calcium channel blocker (%) | 24 | 20 | 0.702 |
| Thiazide diuretic (%) | 20 | 17 | 0.687 |
| Loop diuretic (%) | 65 | 47 | 0.034 |
| Spironolactone (%) | 11 | 2 | 0.036 |
Values are mean (SD) or %.
BP, blood pressure; HTN, hypertension; TAVR, transcatheter aortic valve replacement.